CASE 122: COMPLEMENTARY ROLE OF BONE SCAN AND POSITRON EMISSION TOMOGRAPHY/ COMPUTED TOMOGRAPHY (PET/CT) FINDINGS IN BREAST CANCER

We used virtual navigator real-time ultrasound (US) fusion imaging with 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) to identify a lesion that could not be detected on the US alone in a preoperative breast cancer patient. Of the patient’s two lesions of breast cancer, the calcified lesion could not be identified by US alone. By fusing US with 18F-FDG PET/CT, which had been performed in advance, the location of the lesion could be estimated and marked, which benefited planning an appropriate surgery. The fusion of US and 18F-FDG PET/CT was a simple and noninvasive method for identifying the lesions detected by 18F-FDG PET/CT.

Download Full-text

Role of PET-CT (Positron Emission Tomography-Computed Tomography) in Cancer Evaluation and Treatment

World Journal of Nuclear Science and Technology ◽

10.4236/wjnst.2022.121002 ◽

2022 ◽

Vol 12 (01) ◽

pp. 11-20

Author(s):

Balireddy Vasundhara ◽

Pottumuthu Hemalatha ◽

Pakalapati Satya Sarath Kumar Raju

Keyword(s):

Computed Tomography ◽

Positron Emission Tomography ◽

Emission Tomography ◽

Positron Emission ◽

Pet Ct

Download Full-text

Molecular imaging and immunotherapy

The International Journal of Biological Markers ◽

10.1177/1724600819899099 ◽

2020 ◽

Vol 35 (1_suppl) ◽

pp. 37-41

Author(s):

Laura Evangelista

Keyword(s):

Computed Tomography ◽

Lung Cancer ◽

Positron Emission Tomography ◽

Clinical Practice ◽

Fdg Pet ◽

Emission Tomography ◽

Positron Emission ◽

Pet Ct ◽

Fdg Pet Ct

The utility of positron emission tomography (PET) for the evaluation of response to immunotherapy has been considered a hot topic, particularly in the last 2 to 3 years. Different experiences have been collected in clinical practice, with 18F-Fluorodeoxyglucose (FDG) PET/computed tomography (CT), particularly in patients affected by lymphoma, malignant melanoma, and lung cancer. It has been tested in different settings of disease, from the prediction to the prognosis relative to the response to immunotherapy. In the present mini-review, some evidence is reported about the role of FDG PET/CT in patient candidates to or treated with immunotherapy.

Download Full-text

The Role of Positron Emission Tomography/Computed Tomography in Planning Radiotherapy in Endometrial Cancer

International Journal of Gynecological Cancer ◽

10.1097/igc.0000000000000393 ◽

2015 ◽

Vol 25 (4) ◽

pp. 645-649 ◽

Cited By ~ 7

Author(s):

Bryony Simcock ◽

Kailash Narayan ◽

Elizabeth Drummond ◽

David Bernshaw ◽

Elizabeth Wells ◽

...

Keyword(s):

Computed Tomography ◽

Positron Emission Tomography ◽

Endometrial Cancer ◽

Adjuvant Radiotherapy ◽

Emission Tomography ◽

Optimal Method ◽

Positron Emission ◽

Pet Ct ◽

High Risk Disease

ObjectiveThe optimal method of assessing disease distribution in endometrial cancer is widely debated. Knowledge of disease distribution assists in planning adjuvant radiotherapy; in this study we used positron emission tomography/computed tomography (PET/CT) to assess disease distribution before radiotherapy.MethodsSeventy-three consecutive patients referred to the Peter MacCallum Cancer Centre for adjuvant radiotherapy for endometrial cancer, with either high-risk disease after a hysterectomy or recurrent disease, had a PET/CT before treatment. The findings on PET/CT and clinical course were recorded.ResultsPET/CT found additional disease in 35% of postoperative patients, changing planned treatment in 31%. In the group with known recurrence, additional disease was found in 72%, changing management in 36%.ConclusionsPET/CT is a valuable tool for planning radiotherapy in endometrial cancer.

Download Full-text